SOHO Italy

www.sohoitaly.it

 

SOHO 4th Italian Conference
Avatar

SOHO Italy 2022: Phase 3 AGILE Study - A Global, Randomized, Double-Blind Study of Ivo + Aza vs. Placebo + Aza in Newly Diagnosed AML With an IDH1 Mutation

By SOHO 4th Italian Conference FEATURING Claudio Cerchione
By SOHO 4th Italian Conference FEATURING Claudio Cerchione
16 views
November 28, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Leukemia
07:55

SOHO Italy 2022: Targeting Novel Oncogenic Dependencies in AML With …

SOHO 4th Italian Conference

S. Peruzzi

16 views
09:58

SOHO Italy 2022: Role of BCOR and DNMT3A Cooperation in the Epigenet…

SOHO 4th Italian Conference

A. Scialdone

25 views
15:16

SOHO Italy 2022: How I Treat Blastic Plasmacytoid Dendritic Cell Neo…

SOHO 4th Italian Conference

N. Pemmaraju

18 views
17:22

SOHO Italy 2022: Mutation Profiling of AML Patients

SOHO 4th Italian Conference

N. Daver

114 views
12:25

SOHO Italy 2022: How I Treat Lymphoblastic Leukemia

SOHO 4th Italian Conference

G. Martinelli

71 views
14:30

How I Treat the Older Adult With ALL

Elias Jabbour

210 views
12:48

SOHO Italy 2022: Approach to pH+ and pH-Like ALL

SOHO 4th Italian Conference

C. Papayannidis

35 views
16:32

SOHO Italy 2022: How I Treat CML at MDACC in 2022

SOHO 4th Italian Conference

E. Jabbour

25 views
15:17

SOHO Italy 2022: How I Treat CLL at MDACC

SOHO 4th Italian Conference

A. Ferrajoli

21 views
16:34

SOHO Italy 2022: The History of CML - From Nightmare to the Cure

SOHO 4th Italian Conference

G. Saglio

16 views
15:59

Non-Intensive Treatment of Older/Unfit Patients With AML

SOHO 4th Italian Conference

T. Kadia

165 views
11:33

SOHO Italy 2022: Mutations in AML and the Importance of Molecular Te…

SOHO 4th Italian Conference

G. Martinelli

75 views
18:58

SOHO Italy 2022: FLT3 Mutations in AML

SOHO 4th Italian Conference

N. Daver

68 views
08:12

SOHO Italy 2022: Why We Should Not Forget Glasdegib in AML

SOHO 4th Italian Conference

A. de la Fuente

119 views
08:05

SOHO Italy 2022: Phase 3 AGILE Study - A Global, Randomized, Double-…

SOHO 4th Italian Conference

C. Cerchione

16 views
16:47

SOHO Italy 2022: Immune Antibodies and Cellular Therapies in AML

SOHO 4th Italian Conference

N. Daver

14 views
14:16

SOHO Italy 2022: Secondary AML - What’s New

SOHO 4th Italian Conference

A. Isidori

94 views
10:25

SOHO Italy 2022: Pivekimab Sunirine Triplet With Aza & Ven Shows Bro…

SOHO 4th Italian Conference

N. Daver

15 views
16:47

SOHO Italy 2022: New Insights Into AML Biology and Their Concrete an…

SOHO 4th Italian Conference

I. Iacobucci

33 views
15:43

SOHO Italy 2022: Pro-Apoptotic Pathways in AML

SOHO 4th Italian Conference

S. Galimberti

8 views
13:17

SOHO Italy 2022: New Frontiers in Overcoming Environment-Mediated Dr…

SOHO 4th Italian Conference

C. Cerchione

26 views
20:11

SOHO Italy 2022: Present and Future Perspective for Cellular Therapy…

SOHO 4th Italian Conference

A. Rambaldi

65 views
14:06

Maintenance in AML: Trials or Reality?

SOHO 4th Italian Conference

M. Gottardi

86 views
20:27

SOHO Italy 2022: Next Questions in ALL

SOHO 4th Italian Conference

G. Martinelli

34 views
26:45

SOHO Italy 2022: State-of-the-Art and Next Questions in CML Therapy

SOHO 4th Italian Conference

G. Saglio

18 views